Penn Family Screening for Familial Hypercholesterolemia

NAEnrolling by invitationINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

January 24, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Familial Hypercholesterolemia
Interventions
BEHAVIORAL

Cascade screening

FH is a genetic condition that causes high LDL cholesterol starting at birth. When one individual with FH is diagnosed, it is important that biological family members are also screened, since there is a 50% chance that each first-degree relative will have also inherited FH. More distant relatives may also have inherited FH. This evidence-based process is known as cascade screening.

Trial Locations (1)

19104

University of Pennsylvania, Perelman School of Medicine, Philadelphia

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

Family Heart Foundation

UNKNOWN

lead

Northwestern University

OTHER